_id
69104f6bccc777a4e85d539a
Ticker
CLB
Name
Core Laboratories NV
Exchange
NYSE
Address
6316 Windfern Road, Houston, TX, United States, 77040
Country
USA
Sector
Energy
Industry
Oil & Gas Equipment & Services
Currency
USD
Website
https://www.corelab.com
Description
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Last Close
17.01
Volume
178023
Current Price
17.11
Change
0.5878894767783531
Last Updated
2025-11-29T11:31:29.680Z
Image
data:image/webp;base64,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
Ipo Date
1995-09-20T00:00:00.000Z
Market Cap
708097024
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3
Target Price
14
Strong Buy
0
Buy
1
Hold
3
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
134521000
Cost Of Revenue
108495000
Gross Profit
26026000
Operating Expenses
5098000
Operating Income
20928000
Interest Expense
2650000
Pretax Income
18278000
Net Income
14239000
Eps
0.302455499384001
Dividends Per Share
465000
Shares Outstanding
46563387
Income Tax Expense
3754000
EBITDA
24522000
Operating Margin
15.557422261208288
Total Other Income Expense Net
-2650000
Cash
25629000
Short Term Investments
-
Receivables
124974000
Inventories
58241000
Total Current Assets
226914000
Property Plant Equipment
152011000
Total Assets
591360000
Payables
36945000
Short Term Debt
11474000
Long Term Debt
114103000
Total Liabilities
313972000
Equity
271347000
Depreciation
3594000
Change In Working Capital
-4890000
Cash From Operations
8502000
Capital Expenditures
3032000
Cash From Investing
2393000
Cash From Financing
-16454000
Net Change In Cash
-5559000
PE
22.2059
PB
2.920828791178823
ROE
5.2475243875922715
ROA
2.407839556277056
FCF
5470000
Fcf Percent
0.04066279614335308
Piotroski FScore
3
Health Score
49
Deep Value Investing Score
4
Defensive Investing Score
6
Dividend Investing Score
3.5
Economic Moat Investing Score
6.3
Garp Investing Score
5.5
Growth Investing Score
5
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
6.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
134521000
Quarters > 0 > income Statement > cost Of Revenue
108495000
Quarters > 0 > income Statement > gross Profit
26026000
Quarters > 0 > income Statement > operating Expenses
5098000
Quarters > 0 > income Statement > operating Income
20928000
Quarters > 0 > income Statement > interest Expense
2650000
Quarters > 0 > income Statement > pretax Income
18278000
Quarters > 0 > income Statement > net Income
14239000
Quarters > 0 > income Statement > eps
0.302455499384001
Quarters > 0 > income Statement > dividends Per Share
465000
Quarters > 0 > income Statement > shares Outstanding
47078000
Quarters > 0 > income Statement > income Tax Expense
3754000
Quarters > 0 > income Statement > EBITDA
24522000
Quarters > 0 > income Statement > operating Margin
15.557422261208288
Quarters > 0 > income Statement > total Other Income Expense Net
-2650000
Quarters > 0 > balance Sheet > cash
25629000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
124974000
Quarters > 0 > balance Sheet > inventories
58241000
Quarters > 0 > balance Sheet > total Current Assets
226914000
Quarters > 0 > balance Sheet > property Plant Equipment
152011000
Quarters > 0 > balance Sheet > total Assets
591360000
Quarters > 0 > balance Sheet > payables
36945000
Quarters > 0 > balance Sheet > short Term Debt
11474000
Quarters > 0 > balance Sheet > long Term Debt
114103000
Quarters > 0 > balance Sheet > total Liabilities
313972000
Quarters > 0 > balance Sheet > equity
271347000
Quarters > 0 > cash Flow > net Income
14524000
Quarters > 0 > cash Flow > depreciation
3594000
Quarters > 0 > cash Flow > change In Working Capital
-4890000
Quarters > 0 > cash Flow > cash From Operations
8502000
Quarters > 0 > cash Flow > capital Expenditures
3032000
Quarters > 0 > cash Flow > cash From Investing
2393000
Quarters > 0 > cash Flow > cash From Financing
-16454000
Quarters > 0 > cash Flow > net Change In Cash
-5559000
Quarters > 0 > ratios > PE
0.302455499384001
Quarters > 0 > ratios > PB
2.920828791178823
Quarters > 0 > ratios > ROE
5.2475243875922715
Quarters > 0 > ratios > ROA
2.407839556277056
Quarters > 0 > ratios > FCF
5470000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.04066279614335308
Quarters > 0 > health Score
49
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
130159000
Quarters > 1 > income Statement > cost Of Revenue
107371000
Quarters > 1 > income Statement > gross Profit
22788000
Quarters > 1 > income Statement > operating Expenses
7497000
Quarters > 1 > income Statement > operating Income
15291000
Quarters > 1 > income Statement > interest Expense
2711000
Quarters > 1 > income Statement > pretax Income
12580000
Quarters > 1 > income Statement > net Income
10636000
Quarters > 1 > income Statement > eps
0.22387337136121577
Quarters > 1 > income Statement > dividends Per Share
505192
Quarters > 1 > income Statement > shares Outstanding
47509000
Quarters > 1 > income Statement > income Tax Expense
1911000
Quarters > 1 > income Statement > EBITDA
22645000
Quarters > 1 > income Statement > operating Margin
11.747939059150731
Quarters > 1 > income Statement > total Other Income Expense Net
-2711000
Quarters > 1 > balance Sheet > cash
31188000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
127952000
Quarters > 1 > balance Sheet > inventories
59773000
Quarters > 1 > balance Sheet > total Current Assets
237677000
Quarters > 1 > balance Sheet > property Plant Equipment
153043000
Quarters > 1 > balance Sheet > total Assets
602111000
Quarters > 1 > balance Sheet > payables
41699000
Quarters > 1 > balance Sheet > short Term Debt
11508000
Quarters > 1 > balance Sheet > long Term Debt
124613000
Quarters > 1 > balance Sheet > total Liabilities
334808000
Quarters > 1 > balance Sheet > equity
261283000
Quarters > 1 > cash Flow > net Income
10636000
Quarters > 1 > cash Flow > depreciation
3670000
Quarters > 1 > cash Flow > change In Working Capital
1317553
Quarters > 1 > cash Flow > cash From Operations
14717193
Quarters > 1 > cash Flow > capital Expenditures
4633093
Quarters > 1 > cash Flow > cash From Investing
-1677646
Quarters > 1 > cash Flow > cash From Financing
-3494332
Quarters > 1 > cash Flow > net Change In Cash
9081000
Quarters > 1 > ratios > PE
0.22387337136121577
Quarters > 1 > ratios > PB
3.061102387066897
Quarters > 1 > ratios > ROE
4.070681980840698
Quarters > 1 > ratios > ROA
1.766451700766138
Quarters > 1 > ratios > FCF
10084100
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.07747524181962062
Quarters > 1 > health Score
47
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
123585000
Quarters > 2 > income Statement > cost Of Revenue
103186000
Quarters > 2 > income Statement > gross Profit
20399000
Quarters > 2 > income Statement > operating Expenses
15982000
Quarters > 2 > income Statement > operating Income
4417000
Quarters > 2 > income Statement > interest Expense
2602000
Quarters > 2 > income Statement > pretax Income
1815000
Quarters > 2 > income Statement > net Income
-154000
Quarters > 2 > income Statement > eps
-0.0032924978085647704
Quarters > 2 > income Statement > dividends Per Share
469000
Quarters > 2 > income Statement > shares Outstanding
46773000
Quarters > 2 > income Statement > income Tax Expense
1746000
Quarters > 2 > income Statement > EBITDA
8097000
Quarters > 2 > income Statement > operating Margin
3.574058340413481
Quarters > 2 > income Statement > total Other Income Expense Net
-2602000
Quarters > 2 > balance Sheet > cash
22107000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
130986000
Quarters > 2 > balance Sheet > inventories
59031000
Quarters > 2 > balance Sheet > total Current Assets
228768000
Quarters > 2 > balance Sheet > property Plant Equipment
155433000
Quarters > 2 > balance Sheet > total Assets
591519000
Quarters > 2 > balance Sheet > payables
38497000
Quarters > 2 > balance Sheet > short Term Debt
11654000
Quarters > 2 > balance Sheet > long Term Debt
124367000
Quarters > 2 > balance Sheet > total Liabilities
332163000
Quarters > 2 > balance Sheet > equity
253388000
Quarters > 2 > cash Flow > net Income
69000
Quarters > 2 > cash Flow > depreciation
3717000
Quarters > 2 > cash Flow > change In Working Capital
-1841000
Quarters > 2 > cash Flow > cash From Operations
6660000
Quarters > 2 > cash Flow > capital Expenditures
3579000
Quarters > 2 > cash Flow > cash From Investing
772000
Quarters > 2 > cash Flow > cash From Financing
-4482000
Quarters > 2 > cash Flow > net Change In Cash
2950000
Quarters > 2 > ratios > PE
-0.0032924978085647704
Quarters > 2 > ratios > PB
3.1075798972327027
Quarters > 2 > ratios > ROE
-0.06077635878573571
Quarters > 2 > ratios > ROA
-0.026034666680191172
Quarters > 2 > ratios > FCF
3081000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.024930209976938948
Quarters > 2 > health Score
21
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
129237000
Quarters > 3 > income Statement > cost Of Revenue
109863000
Quarters > 3 > income Statement > gross Profit
19374000
Quarters > 3 > income Statement > operating Expenses
5200000
Quarters > 3 > income Statement > operating Income
14174000
Quarters > 3 > income Statement > interest Expense
2629000
Quarters > 3 > income Statement > pretax Income
11545000
Quarters > 3 > income Statement > net Income
7403000
Quarters > 3 > income Statement > eps
0.15496200782868985
Quarters > 3 > income Statement > dividends Per Share
469000
Quarters > 3 > income Statement > shares Outstanding
47773000
Quarters > 3 > income Statement > income Tax Expense
4076000
Quarters > 3 > income Statement > EBITDA
17838000
Quarters > 3 > income Statement > operating Margin
10.967447402833553
Quarters > 3 > income Statement > total Other Income Expense Net
-2629000
Quarters > 3 > balance Sheet > cash
19157000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
127355000
Quarters > 3 > balance Sheet > inventories
59402000
Quarters > 3 > balance Sheet > total Current Assets
226606000
Quarters > 3 > balance Sheet > property Plant Equipment
153551000
Quarters > 3 > balance Sheet > total Assets
590406000
Quarters > 3 > balance Sheet > payables
34549000
Quarters > 3 > balance Sheet > short Term Debt
10690000
Quarters > 3 > balance Sheet > long Term Debt
126111000
Quarters > 3 > balance Sheet > total Liabilities
332669000
Quarters > 3 > balance Sheet > equity
251991000
Quarters > 3 > cash Flow > net Income
7469000
Quarters > 3 > cash Flow > depreciation
3664000
Quarters > 3 > cash Flow > change In Working Capital
9692000
Quarters > 3 > cash Flow > cash From Operations
20615000
Quarters > 3 > cash Flow > capital Expenditures
4381000
Quarters > 3 > cash Flow > cash From Investing
-3559000
Quarters > 3 > cash Flow > cash From Financing
-19373000
Quarters > 3 > cash Flow > net Change In Cash
-2317000
Quarters > 3 > ratios > PE
0.15496200782868985
Quarters > 3 > ratios > PB
3.1916157918338355
Quarters > 3 > ratios > ROE
2.9378033342460643
Quarters > 3 > ratios > ROA
1.2538829212440252
Quarters > 3 > ratios > FCF
16234000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.125614181697192
Quarters > 3 > health Score
50
Valuation > metrics > PE
22.2059
Valuation > metrics > PB
2.920828791178823
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
5.2475243875922715
Profitability > metrics > ROA
6.27506456190451
Profitability > metrics > Net Margin
0.10584964429345604
Profitability > final Score
45
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.1570866823661217
Risk > metrics > Interest Coverage
7.897358490566038
Risk > final Score
62
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.686466056713273
Liquidity > metrics > Quick Ratio
3.4836118052830503
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
69.38897612933103
Prev Valuations > 1
48.92420102767297
Prev Valuations > 2
68.08384208166164
Prev Profitabilities > 0
34
Prev Profitabilities > 1
0
Prev Profitabilities > 2
24
Prev Risks > 0
53
Prev Risks > 1
37
Prev Risks > 2
52
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T15:19:06.385Z
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAriel Investments LLC Has $149.49 Million Stock Position in Core Laboratories Inc. $CLB - MarketBeat
12/10/2025
Ariel Investments LLC Has $149.49 Million Stock Position in Core Laboratories Inc. $CLB MarketBeat
Read more →Fisher Asset Management LLC Sells 143,838 Shares of Core Laboratories Inc. $CLB - MarketBeat
12/4/2025
Fisher Asset Management LLC Sells 143,838 Shares of Core Laboratories Inc. $CLB MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$14
Analyst Picks
Strong Buy
0
Buy
1
Hold
3
Sell
1
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 140.80% of the total shares of Core Laboratories NV
1.
Ariel Investments, LLC(27.672%)
since
2025/06/30
2.
BlackRock Inc(15.6352%)
since
2025/06/30
3.
Disciplined Growth Investors Inc(11.6026%)
since
2025/06/30
4.
Ariel Fund Investor(11.13%)
since
2025/06/30
5.
Vanguard Group Inc(9.5516%)
since
2025/06/30
6.
Earnest Partners LLC(7.6834%)
since
2025/06/30
7.
iShares Core S&P Small-Cap ETF(5.9714%)
since
2025/08/31
8.
State Street Corp(4.6121%)
since
2025/06/30
9.
Disciplined Growth - Mid Cap Growth(3.2437%)
since
2024/12/31
10.
Vanguard Total Stock Mkt Idx Inv(3.1357%)
since
2025/07/31
11.
Ariel Appreciation Investor(2.9186%)
since
2025/06/30
12.
Harbor Small Cap Value Instl(2.9075%)
since
2025/06/30
13.
Dimensional Fund Advisors, Inc.(2.4939%)
since
2025/06/30
14.
iShares Russell 2000 ETF(2.4185%)
since
2025/08/31
15.
Geode Capital Management, LLC(2.3768%)
since
2025/06/30
16.
T. Rowe Price Investment Management,Inc.(1.866%)
since
2025/06/30
17.
Fisher Asset Management, LLC(1.8504%)
since
2025/06/30
18.
Royce & Associates, LP(1.647%)
since
2025/06/30
19.
T. Rowe Price US Smlr Coms Eq A(1.5271%)
since
2025/07/31
20.
Northern Trust Corp(1.2973%)
since
2025/06/30
21.
Royce Small-Cap Quality Value Composite(1.222%)
since
2025/06/30
22.
Royce Small-Cap Total Return Invmt(1.222%)
since
2025/06/30
23.
Gendell Jeffrey L(1.2144%)
since
2025/06/30
24.
Vanguard Small Cap Index(1.213%)
since
2025/07/31
25.
Fred Alger Management, LLC(1.1609%)
since
2025/06/30
26.
Charles Schwab Investment Management Inc(1.1536%)
since
2025/06/30
27.
Vanguard Institutional Extnd Mkt Idx Tr(1.0722%)
since
2025/07/31
28.
Morgan Stanley - Brokerage Accounts(1.0269%)
since
2025/06/30
29.
Fidelity Small Cap Index(1.0054%)
since
2025/06/30
30.
Hotchkis & Wiley Capital Management LLC(0.9764%)
since
2025/06/30
31.
iShares Russell 2000 Value ETF(0.8914%)
since
2025/08/31
32.
SPDR® Portfolio S&P 600™ Sm Cap ETF(0.8764%)
since
2025/08/29
33.
Bank of New York Mellon Corp(0.8647%)
since
2025/06/30
34.
Vanguard Explorer Value Inv(0.8608%)
since
2025/06/30
35.
Disciplined Growth Investors(0.7848%)
since
2025/06/30
36.
Vanguard Small Cap Value Index Inv(0.7846%)
since
2025/07/31
37.
Van Eck Associates Corporation(0.7455%)
since
2025/06/30
38.
UBS Group AG(0.7312%)
since
2025/06/30
39.
Vanguard Energy ETF(0.73%)
since
2025/07/31
40.
Vanguard Tax-Managed Small Cap Adm(0.7253%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.